Today’s complex clinical care landscape requires equally challenging case-based discussions to foster collaboration and innovative treatment approaches.
Founded upon the AGA Clinical Care Pathways and evidence-based literature, the AGA University course, Optimizing Management in IBD: Challenging Cases, is a 45-minute program designed to test — and sharpen — clinicians’ knowledge of best practice surrounding the treatment of patients with inflammatory bowel disease (IBD).
Case vignettes of patients with ulcerative colitis and Crohn’s disease are presented with accompanying challenge questions, in addition to feedback on medical management from the following esteemed faculty: Gil Y. Melmed, MD, MS (chair), Adam S. Cheifetz, MD, and Gary R. Lichtenstein, MD, FACP, FACG, AGAF.
Complete this free course by Wednesday, Dec. 25, to receive 0.75 AMA PRA Category 1 Credit(s)™ and be able to:
- 1. Differentiate between current, novel and future IBD therapies based on their efficacy and safety data.
- 2. Devise an individualized and adaptable treatment plan for patients with IBD to maximize remission, avoid relapse and minimize toxicity.
- 3. Assess disease progression and utilize drug monitoring strategies to optimize treatment of patients with IBD.
- 4. Employ a strong patient-provider collaborative approach to managing patients with IBD that includes patient education, engagement and shared decision making.
This activity is supported by independent educational grants from Celgene Corporation, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Salix Pharmaceuticals.